# To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China

> **NCT04823221** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 22 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DEVICE:** Rezūm System

## Key facts

- **NCT ID:** NCT04823221
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-10
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04823221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04823221, "To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04823221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*